Document is current
Any future updates will be listed below
-
Authors
Takedani, Kai
Notsu, Masakazu
Koike, Sayo
Yamauchi, Mika
Mori, Takayasu
Sohara, Eisei
Yamauchi, Asuka
Yoshikane, Kaori
Ito, Takafumi
Kanasaki, Keizo https://orcid.org/0000-0002-9563-502X
- License Information
-
More Information
Article History
Received: 18 June 2020
Accepted: 26 November 2020
First Online: 4 January 2021
Compliance with ethical standards
:
: KK collaborated with the study in the topic without any association with this manuscript. KK received lecture fees from Daiichi-Sankyo Pharma, Tanabe-Mitsubishi Pharma, Boehringer Ingelheim, Eli Lilly, Sanofi, Taisho Pharma. KK is under a consultancy agreement with Boehringer Ingelheim. MY has received lecture fees from Chugai Pharmaceutical. TI received lecture fees from Kyowa Kirin, Chugai Pharmaceutical, Otsuka Pharmaceutical, Daiichi-Sankyo Company, Terumo Corporation, Teijin Pharma, Japan Blood Products Organization, Novartis Pharma, MSD K.K., Mitsubishi-Tanabe Pharma, and Kissei Pharmaceutical. The other authors declare no conflicts of interest associated with this manuscript.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study.
